We are live on ! Find out more
TPTX

Turning Point Therapeutics, Inc. Common Stock
TPTX

Delisted

TPTX was delisted on the 16th of August, 2022.

Back to rankings

155 hedge funds and large institutions have $1.24B invested in Turning Point Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 66 increasing their positions, 53 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 53

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

10% less funds holding

Funds holding: 172 → 155 (-17)

38% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 40

42% less capital invested

Capital invested by funds: $2.15B → $1.24B (-$905M)

98% less call options, than puts

Call options by funds: $5K | Put options by funds: $236K

Holders
155
Holders Change
-17
Holders Change %
-9.88%
% of All Funds
2.44%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
66
Reduced
53
Closed
40
Calls
$5K
Puts
$236K
Net Calls
-$231K
Net Calls Change
+$1.04M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$28.4M
2
CAM
Cormorant Asset Management
Massachusetts
+$22.7M
3
BC
Boxer Capital
California
+$13.4M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$11.5M
5
Morgan Stanley
Morgan Stanley
New York
+$7.95M

Top Sellers

Rank Fund Capital Flow
1
American Century Companies
American Century Companies
Missouri
-$26.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$19.6M
3
AG
Artal Group
Luxembourg
-$11.9M
4
FLAM
First Light Asset Management
Minnesota
-$11.5M
5
FCM
Frontier Capital Management
Massachusetts
-$8M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
76
Algert Global
California
$886K +$955K +28,426 +621%
Fiera Capital (Canada)
77
Fiera Capital (Canada)
Quebec, Canada
$827K -$36K -1,072 -3%
Victory Capital Management
78
Victory Capital Management
Texas
$752K +$648K +19,290 +308%
MIM
79
MetLife Investment Management
New Jersey
$686K +$304K +9,050 +55%
CANY
80
Caxton Associates (New York)
New York
$685K +$331K +9,836 +63%
EAM
81
Erste Asset Management
Austria
$671K +$208K +6,200 +33%
Two Sigma Advisers
82
Two Sigma Advisers
New York
$634K +$793K +23,600 New
BNP Paribas Financial Markets
83
BNP Paribas Financial Markets
France
$618K -$274K -8,149 -26%
AIG
84
American International Group
New York
$613K -$54K -1,607 -7%
SG Americas Securities
85
SG Americas Securities
New York
$609K +$428K +12,722 +128%
Walleye Capital
86
Walleye Capital
New York
$606K +$758K +22,556 New
TI
87
Trexquant Investment
Connecticut
$588K +$736K +21,893 New
HS
88
HighVista Strategies
Massachusetts
$565K +$707K +21,037 New
State Board of Administration of Florida Retirement System
89
State Board of Administration of Florida Retirement System
Florida
$528K – – –
Renaissance Technologies
90
Renaissance Technologies
New York
$502K +$628K +18,700 New
NC
91
NinePointTwo Capital
California
$493K +$617K +18,375 New
VOYA Investment Management
92
VOYA Investment Management
Georgia
$486K -$2.45K -73 -0.4%
DekaBank Deutsche Girozentrale
93
DekaBank Deutsche Girozentrale
Germany
$468K +$16.1K +480 +3%
DA
94
Duality Advisers
Florida
$443K -$467K -13,911 -46%
Allianz Asset Management
95
Allianz Asset Management
Germany
$393K -$1.57M -46,615 -76%
EGM
96
Engineers Gate Manager
New York
$393K +$492K +14,650 New
IA
97
IndexIQ Advisors
New York
$379K +$475K +14,134 New
ProShare Advisors
98
ProShare Advisors
Maryland
$370K -$109K -3,250 -19%
GC
99
Guggenheim Capital
Illinois
$330K +$16.9K +504 +4%
WMSA
100
Weiss Multi-Strategy Advisers
New York
$320K -$33.9K -1,009 -8%
2 3
4
5 6

TPTX Hedge Fund Activity: Q1 2022 in Review

155 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Turning Point Therapeutics, Inc. Common Stock (TPTX) for Q1 2022, worth a combined $1.24B — down 42% from $2.15B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of TPTX and 25 opened new positions — a net loss of 15 holders — while 53 trimmed existing stakes and 66 added.

The largest buyer was State Street, adding an estimated $28.4M. The largest seller was American Century Companies, exiting entirely with an estimated $26.1M sold.

  • 155 institutional investors held Turning Point Therapeutics, Inc. Common Stock (TPTX) as of Q1 2022, down from 172 in Q4 2021.
  • Funds reported $1.24B of Turning Point Therapeutics, Inc. Common Stock stock for Q1 2022, down 42% quarter-over-quarter.
  • 25 funds opened new Turning Point Therapeutics, Inc. Common Stock positions in Q1 2022 and 40 closed out, a net change of -15 holders.
  • The largest Turning Point Therapeutics, Inc. Common Stock buyer in Q1 2022 was State Street, an estimated $28.4M added.
  • The largest Turning Point Therapeutics, Inc. Common Stock seller in Q1 2022 was American Century Companies, an estimated $26.1M sold.

Based on aggregated 13F filings for Q1 2022.